Information about Geographic Areas

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Information about Geographic Areas

Information about Geographic Areas

The Company operates as a single reportable segment and enables customers to perform both research and clinical testing on its nCounter Analysis Systems. The Company has one sales force that sells these systems to both research and clinical testing labs, and its nCounter Elements reagents can be used for both research and diagnostic testing. In addition, the Company’s Prosigna Breast Cancer Assay is marketed to clinical laboratories. The Company has also entered into collaboration agreements with Celgene, Merck and Medivation and Astellas.

The following table of total revenue is based on the geographic location of the Company’s customers, distributors and collaborators. For sales to distributors, their geographic location may be different from the geographic locations of the ultimate end user. Americas consists of the United States, Canada, Mexico and South America; and Asia Pacific includes Japan, China, South Korea, Singapore, Malaysia and Australia. Total revenue by geography was as follows (in thousands):

	Three Months Ended March 31,
	2016		2015
Americas	$	10,083	$	7,523
Europe & Middle East	2,853		2,943
Asia Pacific	1,761		1,127
Total revenue	$	14,697	$	11,593

Total revenue in the United States was $9.6 million and $7.2 million for the three months ended March 31,2016 and 2015, respectively.

The Company’s assets are primarily located in the United States and not allocated to any specific geographic region. Substantially all of the Company’s long-lived assets are located in the United States.